Works matching IS 00278874 AND DT 2010 AND VI 102 AND IP 24

Results: 22

Response: Re: The Role of SATB1 in Breast Cancer Pathogenesis.

Published in:

2010

By:

IORNS, ELIZABETH;
HNATYSZYN, H. JAMES;
SEO, PEARL;
CLARKE, JENNIFER;
WARD, TOBY;
LIPPMAN, MARC E.

Publication type:

Letter

How To Handle Positive Sentinel Nodes?

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1820, doi. 10.1093/jnci/djq522

By:

Schmidt, Charlie

Publication type:

Article

IN THIS ISSUE.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1813, doi. 10.1093/jnci/djq519
Publication type:: Article

Reduction in Physician Reimbursement and Use of Hormone Therapy in Prostate Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1826, doi. 10.1093/jnci/djq417

By:

Elliott, Sean P.;
Jarosek, Stephanie L.;
Wilt, Timothy J.;
Virnig, Beth A.

Publication type:

Article

Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1845, doi. 10.1093/jnci/djq409

By:

Bonilla, Luisa;
Ben-Aharon, Irit;
Vidal, Liat;
Gafter-Gvili, Anat;
Leibovici, Leonard;
Stemmer, Salomon M.

Publication type:

Article

Decreased Physician Reimbursement for Hormone Therapy May Have Reduced Over-treatment of Low-risk Prostate Cancer.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq532
Publication type:: Article

Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1855, doi. 10.1093/jnci/djq457

By:

Joong Sup Shim;
Matsui, Yoshiyuki;
Bhat, Shridhar;
Nacev, Benjamin A.;
Jing Xu;
Bhang, Hyo-eun C.;
Dhara, Surajit;
Kee Chung Han;
Chong, Curtis R.;
Pomper, Martin G.;
So, Alan;
Liu, Jun O.

Publication type:

Article

Pancreatic Cancer: Will Incremental Advances Begin To Make a Difference?

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1821, doi. 10.1093/jnci/djq521

By:

Hotzman, David C.

Publication type:

Article

Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1874, doi. 10.1093/jnci/djq443

By:

Metcalfe, Kelly;
Lubinski, Jan;
Lynch, Henry T.;
Ghadirian, Parviz;
Foulkes, William D.;
Kim-Sing, Charmaine;
Neuhausen, Susan;
Tung, Nadine;
Rosen, Barry;
Gronwald, Jacek;
Ainsworth, Peter;
Sweet, Kevin;
Eisen, Andrea;
Ping Sun;
Narod, Steven A.

Publication type:

Article

EDITORIAL BOARD.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq545
Publication type:: Article

Medicare Reimbursement and Prescribing Hormone Therapy for Prostate Cancer.

Published in:

2010

By:

Keating, Nancy L.

Publication type:

Editorial

Re: The Role of SATB1 in Breast Cancer Pathogenesis.

Published in:

2010

By:

KOHWI-SHIGEMATSU, TERUMI;
HYE-JUNG HAN;
RUSSO, JOSE;
KOHWI, YOSHINORI

Publication type:

Letter

StatBite U.S. Pancreatic Cancer Rates.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1822, doi. 10.1093/jnci/djq517
Publication type:: Article

JAPANESE JOURNAL OF CLINICAL ONCOLOGY.

Published in:: 2010
Publication type:: Table of Contents

Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial.

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1835, doi. 10.1093/jnci/djq442

By:

Elmets, Craig A.;
Viner, Jaye L.;
Pentland, Alice P.;
Cantrell, Wendy;
Hui-Yi Lin;
Bailey, Howard;
Sewon Kang;
Linden, Kenneth G.;
Heffernan, Michael;
Duvic, Madeleine;
Richmond, Ellen;
Elewski, Boni E.;
Umar, Asad;
Bell, Walter;
Gordon, Gary B.

Publication type:

Article

We wish to thank the following reviewers for their generous assistance in evaluating manuscripts submitted to the Journal of the National Cancer Institute during the past year.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1882, doi. 10.1093/jnci/djq459
Publication type:: Article

Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1815, doi. 10.1093/jnci/djq466

By:

Meyskens Jr., Frank L.;
McLaren, Christine E.

Publication type:

Article

TABLE OF CONTENTS.

Published in:: 2010
Publication type:: Table of Contents

Meta-analysis: Should It be More Than the Sum of Its Parts?

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1817, doi. 10.1093/jnci/djq469

By:

Herbolsheimer, Pia;
Swain, Sandra M.

Publication type:

Article

Targeted Epigenetic Therapies: The Next Frontier?

Published in:

JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1824, doi. 10.1093/jnci/djq520

By:

Tuma, Rabiya S.

Publication type:

Article

Celecoxib May Be Effective in Preventing Nonmelanoma Skin Cancers.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq523
Publication type:: Article

Cover.

Published in:: JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq547
Publication type:: Article